List of All Articles with Tag 'd'

The European Union is moving ahead with a proposal to tax profits from more than €200 billion ($218

Ford Motor Co. restored financial guidance Thursday, saying profits would come in lower than earlier projections due to

Meta says it has found and disabled thousands of fake Facebook accounts linked to China that were used to spread politically partisan content in the United States before next year’s election

The Biden administration announced a proposal on Thursday which would require water systems across the U.S. to replace

The number of children living in temporary accommodation in England has reached a record high, according to new

Ford Motor Co. says a six-week strike by the United Auto Workers union cut sales by about 100,000 vehicles and cost the company $1.7 billion in lost profits this year

Pope Francis says he is suffering from acute and infectious bronchitis

(Reuters) -Ford Motor on Thursday said the U.S. auto workers' strike has led to a $1.7 billion hit to its

Radiohead drummer Philip Selway has hinted that the band are ready to reunite after being on hiatus since 2018.

There’s political blood in the water after a series of blows to New York City Mayor Eric Adams,

TD Bank Group reported a fall in its fourth-quarter profit on Thursday, as Canada's second-largest lender set aside

Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.